Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 2, 2002, Pages 287-291

  Kondo, Tsuyoshi ^a   Ishida, Masayuki ^a   Tokinaga, Noboru ^a   Mihara, Kazuo ^a   Yasui Furukori, Norio ^a   Ono, Shingo ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Nemonapride; Plasma drug concentrations; Prolactin; Side effects

Indexed keywords

EMILACE; EMONAPRIDE; PROLACTIN;

ADOLESCENT; ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPOKINESIA; MALE; PROLACTIN BLOOD LEVEL; SALIVATION DISORDER; SCHIZOPHRENIA; SEX DIFFERENCE; TREMOR;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BENZAMIDES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROLACTIN; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 0036138016     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00267-6     Document Type: Article

References (24)

1. Serum chlorpromazine and prolactin levels in paranoid schizophrenic patients and clinical response
2. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice
3. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients
4. Adverse effects of anticholinergic medication in positive schizophrenic symptoms: Theoretical and practical considerations
5. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: A replication study
6. Adverse effects of zotepine and their relationship to serum concentrations of the drugs and prolactin
7. Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist
8. Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin
9. The UKU side effect rating scale
10. Haloperidol plasma levels and clinical response in paranoid schizophrenics
11. A double-blind comparison of a new benzamide compound YM-09151 with haloperidol in the treatment of schizophrenia
12. High-performance liquid chromatographic determination of nemonapride and desmethylnemonapride in human plasma using an electrochemical detection
13. Prolactin response to nemonapride, a new antipsychotic drug, in schizophrenic patients
14. A pilot study of plasma thioridazine and metabolites in chronically treated patients
15. Clinical state, plasma levels of haloperidol and prolactin: A correlation study in chronic schizophrenia
16. Prolactin and schizophrenia
17. Effects of nemonapride on positive and negative symptoms of schizophrenia
18. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: Risperidone compared with antipsychotics hitherto used
19. The role of estrogens in schizophrenia gender differences
20. Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia
21. 3H] raclopride for dopamine D-2 receptor binding to rat striatum
22. Haloperidol blood levels and clinical effects
23. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine